HEADER OXIDOREDUCTASE 23-SEP-13 4C7J TITLE 11B-HYDROXYSTEROID DEHYDROGENASE TYPE I IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: RESIDUES 24-292; COMPND 5 SYNONYM: 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,11-DH, 11-BETA-HSD1, COMPND 6 11B-HYDROXYSTEROID DEHYDROGENASE TYPE 1; COMPND 7 EC: 1.1.1.146; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDOREDUCTASE, CNS PENETRATION, STRUCTURE-BASED DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR F.W.GOLDBERG,A.G.DOSSETTER,J.S.SCOTT,G.R.ROBB,S.BOYD,S.D.GROOMBRIDGE, AUTHOR 2 P.D.KEMMITT,T.SJOGREN,P.MORENTIN GUTIERREZ,J.DE SCHOOLMEESTER, AUTHOR 3 J.G.SWALES,A.V.TURNBULL,M.J.WILD REVDAT 3 08-MAY-24 4C7J 1 REMARK REVDAT 2 04-APR-18 4C7J 1 REMARK REVDAT 1 03-SEP-14 4C7J 0 JRNL AUTH F.W.GOLDBERG,A.G.DOSSETTER,J.S.SCOTT,G.R.ROBB,S.BOYD, JRNL AUTH 2 S.D.GROOMBRIDGE,P.D.KEMMITT,T.SJOGREN,P.M.GUTIERREZ, JRNL AUTH 3 J.DESCHOOLMEESTER,J.G.SWALES,A.V.TURNBULL,M.J.WILD JRNL TITL OPTIMIZATION OF BRAIN PENETRANT 11BETA-HYDROXYSTEROID JRNL TITL 2 DEHYDROGENASE TYPE I INHIBITORS AND IN VIVO TESTING IN DIET- JRNL TITL 3 INDUCED OBESE MICE. JRNL REF J.MED.CHEM. V. 57 970 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24422550 JRNL DOI 10.1021/JM4016729 REMARK 2 REMARK 2 RESOLUTION. 2.16 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.16 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 68.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 46877 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2478 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.16 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.22 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3245 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.17 REMARK 3 BIN R VALUE (WORKING SET) : 0.2290 REMARK 3 BIN FREE R VALUE SET COUNT : 181 REMARK 3 BIN FREE R VALUE : 0.3060 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7952 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 296 REMARK 3 SOLVENT ATOMS : 605 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.18000 REMARK 3 B22 (A**2) : -0.08000 REMARK 3 B33 (A**2) : -0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.340 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.230 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.160 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.300 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.898 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8416 ; 0.014 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11422 ; 1.646 ; 2.000 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1033 ; 5.180 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 309 ;37.291 ;23.750 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1474 ;17.030 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 41 ;14.576 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1348 ; 0.111 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6000 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5131 ; 1.012 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8248 ; 1.929 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3285 ; 3.035 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3161 ; 4.973 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4C7J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1290058050. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAY-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RAXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50932 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.160 REMARK 200 RESOLUTION RANGE LOW (A) : 33.040 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.16 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.55000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 47.84300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.55600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.21750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.55600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 47.84300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.21750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -50.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 24 REMARK 465 GLU A 25 REMARK 465 MET A 286 REMARK 465 ASP A 287 REMARK 465 ARG A 288 REMARK 465 PHE A 289 REMARK 465 ILE A 290 REMARK 465 ASN A 291 REMARK 465 LYS A 292 REMARK 465 ASN B 24 REMARK 465 GLU B 25 REMARK 465 LYS B 292 REMARK 465 ASN C 24 REMARK 465 GLU C 25 REMARK 465 THR C 282 REMARK 465 SER C 283 REMARK 465 TYR C 284 REMARK 465 ASN C 285 REMARK 465 MET C 286 REMARK 465 ASP C 287 REMARK 465 ARG C 288 REMARK 465 PHE C 289 REMARK 465 ILE C 290 REMARK 465 ASN C 291 REMARK 465 LYS C 292 REMARK 465 ASN D 24 REMARK 465 GLU D 25 REMARK 465 GLY D 229 REMARK 465 ILE D 230 REMARK 465 VAL D 231 REMARK 465 SER D 283 REMARK 465 TYR D 284 REMARK 465 ASN D 285 REMARK 465 MET D 286 REMARK 465 ASP D 287 REMARK 465 ARG D 288 REMARK 465 PHE D 289 REMARK 465 ILE D 290 REMARK 465 ASN D 291 REMARK 465 LYS D 292 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 130 -75.57 -116.13 REMARK 500 ASP A 132 60.76 -107.78 REMARK 500 PHE A 144 -64.81 -125.28 REMARK 500 SER A 169 -152.17 -111.89 REMARK 500 LEU A 179 0.11 85.41 REMARK 500 VAL A 180 35.82 -142.83 REMARK 500 ASN A 207 56.75 -92.77 REMARK 500 ASP A 219 33.25 -71.09 REMARK 500 ILE A 230 -54.29 -125.28 REMARK 500 ALA B 65 170.90 177.22 REMARK 500 HIS B 130 -56.69 -132.51 REMARK 500 ASP B 131 -0.64 -160.73 REMARK 500 PHE B 144 -62.07 -124.59 REMARK 500 SER B 169 -151.35 -118.49 REMARK 500 VAL B 180 41.58 -141.67 REMARK 500 ASP B 219 32.08 -67.77 REMARK 500 PHE C 144 -59.04 -125.35 REMARK 500 SER C 169 -144.88 -116.34 REMARK 500 ASP C 219 35.44 -75.63 REMARK 500 LEU C 279 9.59 -68.94 REMARK 500 ALA D 65 -177.36 -175.57 REMARK 500 PHE D 144 -58.72 -121.37 REMARK 500 SER D 169 -149.24 -122.95 REMARK 500 LYS D 174 -23.14 -140.39 REMARK 500 LEU D 179 -4.44 82.04 REMARK 500 ASN D 207 53.57 -91.88 REMARK 500 ASP D 219 43.10 -76.63 REMARK 500 SER D 281 -21.55 -31.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D2010 DISTANCE = 6.05 ANGSTROMS REMARK 525 HOH D2035 DISTANCE = 6.94 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 1286 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 1292 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP C 1282 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP D 1283 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4YQ A 1287 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4YQ B 1293 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4YQ C 1283 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4YQ D 1284 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4C7K RELATED DB: PDB REMARK 900 11B-HYDROXYSTEROID DEHYDROGENASE TYPE I IN COMPLEX WITH INHIBITOR DBREF 4C7J A 24 292 UNP P28845 DHI1_HUMAN 24 292 DBREF 4C7J B 24 292 UNP P28845 DHI1_HUMAN 24 292 DBREF 4C7J C 24 292 UNP P28845 DHI1_HUMAN 24 292 DBREF 4C7J D 24 292 UNP P28845 DHI1_HUMAN 24 292 SEQADV 4C7J LEU A 179 UNP P28845 MET 179 ENGINEERED MUTATION SEQADV 4C7J ARG A 262 UNP P28845 LEU 262 ENGINEERED MUTATION SEQADV 4C7J SER A 272 UNP P28845 CYS 272 ENGINEERED MUTATION SEQADV 4C7J GLU A 278 UNP P28845 PHE 278 ENGINEERED MUTATION SEQADV 4C7J LEU B 179 UNP P28845 MET 179 ENGINEERED MUTATION SEQADV 4C7J ARG B 262 UNP P28845 LEU 262 ENGINEERED MUTATION SEQADV 4C7J SER B 272 UNP P28845 CYS 272 ENGINEERED MUTATION SEQADV 4C7J GLU B 278 UNP P28845 PHE 278 ENGINEERED MUTATION SEQADV 4C7J LEU C 179 UNP P28845 MET 179 ENGINEERED MUTATION SEQADV 4C7J ARG C 262 UNP P28845 LEU 262 ENGINEERED MUTATION SEQADV 4C7J SER C 272 UNP P28845 CYS 272 ENGINEERED MUTATION SEQADV 4C7J GLU C 278 UNP P28845 PHE 278 ENGINEERED MUTATION SEQADV 4C7J LEU D 179 UNP P28845 MET 179 ENGINEERED MUTATION SEQADV 4C7J ARG D 262 UNP P28845 LEU 262 ENGINEERED MUTATION SEQADV 4C7J SER D 272 UNP P28845 CYS 272 ENGINEERED MUTATION SEQADV 4C7J GLU D 278 UNP P28845 PHE 278 ENGINEERED MUTATION SEQRES 1 A 269 ASN GLU GLU PHE ARG PRO GLU MET LEU GLN GLY LYS LYS SEQRES 2 A 269 VAL ILE VAL THR GLY ALA SER LYS GLY ILE GLY ARG GLU SEQRES 3 A 269 MET ALA TYR HIS LEU ALA LYS MET GLY ALA HIS VAL VAL SEQRES 4 A 269 VAL THR ALA ARG SER LYS GLU THR LEU GLN LYS VAL VAL SEQRES 5 A 269 SER HIS CYS LEU GLU LEU GLY ALA ALA SER ALA HIS TYR SEQRES 6 A 269 ILE ALA GLY THR MET GLU ASP MET THR PHE ALA GLU GLN SEQRES 7 A 269 PHE VAL ALA GLN ALA GLY LYS LEU MET GLY GLY LEU ASP SEQRES 8 A 269 MET LEU ILE LEU ASN HIS ILE THR ASN THR SER LEU ASN SEQRES 9 A 269 LEU PHE HIS ASP ASP ILE HIS HIS VAL ARG LYS SER MET SEQRES 10 A 269 GLU VAL ASN PHE LEU SER TYR VAL VAL LEU THR VAL ALA SEQRES 11 A 269 ALA LEU PRO MET LEU LYS GLN SER ASN GLY SER ILE VAL SEQRES 12 A 269 VAL VAL SER SER LEU ALA GLY LYS VAL ALA TYR PRO LEU SEQRES 13 A 269 VAL ALA ALA TYR SER ALA SER LYS PHE ALA LEU ASP GLY SEQRES 14 A 269 PHE PHE SER SER ILE ARG LYS GLU TYR SER VAL SER ARG SEQRES 15 A 269 VAL ASN VAL SER ILE THR LEU CYS VAL LEU GLY LEU ILE SEQRES 16 A 269 ASP THR GLU THR ALA MET LYS ALA VAL SER GLY ILE VAL SEQRES 17 A 269 HIS MET GLN ALA ALA PRO LYS GLU GLU CYS ALA LEU GLU SEQRES 18 A 269 ILE ILE LYS GLY GLY ALA LEU ARG GLN GLU GLU VAL TYR SEQRES 19 A 269 TYR ASP SER SER ARG TRP THR THR LEU LEU ILE ARG ASN SEQRES 20 A 269 PRO SER ARG LYS ILE LEU GLU GLU LEU TYR SER THR SER SEQRES 21 A 269 TYR ASN MET ASP ARG PHE ILE ASN LYS SEQRES 1 B 269 ASN GLU GLU PHE ARG PRO GLU MET LEU GLN GLY LYS LYS SEQRES 2 B 269 VAL ILE VAL THR GLY ALA SER LYS GLY ILE GLY ARG GLU SEQRES 3 B 269 MET ALA TYR HIS LEU ALA LYS MET GLY ALA HIS VAL VAL SEQRES 4 B 269 VAL THR ALA ARG SER LYS GLU THR LEU GLN LYS VAL VAL SEQRES 5 B 269 SER HIS CYS LEU GLU LEU GLY ALA ALA SER ALA HIS TYR SEQRES 6 B 269 ILE ALA GLY THR MET GLU ASP MET THR PHE ALA GLU GLN SEQRES 7 B 269 PHE VAL ALA GLN ALA GLY LYS LEU MET GLY GLY LEU ASP SEQRES 8 B 269 MET LEU ILE LEU ASN HIS ILE THR ASN THR SER LEU ASN SEQRES 9 B 269 LEU PHE HIS ASP ASP ILE HIS HIS VAL ARG LYS SER MET SEQRES 10 B 269 GLU VAL ASN PHE LEU SER TYR VAL VAL LEU THR VAL ALA SEQRES 11 B 269 ALA LEU PRO MET LEU LYS GLN SER ASN GLY SER ILE VAL SEQRES 12 B 269 VAL VAL SER SER LEU ALA GLY LYS VAL ALA TYR PRO LEU SEQRES 13 B 269 VAL ALA ALA TYR SER ALA SER LYS PHE ALA LEU ASP GLY SEQRES 14 B 269 PHE PHE SER SER ILE ARG LYS GLU TYR SER VAL SER ARG SEQRES 15 B 269 VAL ASN VAL SER ILE THR LEU CYS VAL LEU GLY LEU ILE SEQRES 16 B 269 ASP THR GLU THR ALA MET LYS ALA VAL SER GLY ILE VAL SEQRES 17 B 269 HIS MET GLN ALA ALA PRO LYS GLU GLU CYS ALA LEU GLU SEQRES 18 B 269 ILE ILE LYS GLY GLY ALA LEU ARG GLN GLU GLU VAL TYR SEQRES 19 B 269 TYR ASP SER SER ARG TRP THR THR LEU LEU ILE ARG ASN SEQRES 20 B 269 PRO SER ARG LYS ILE LEU GLU GLU LEU TYR SER THR SER SEQRES 21 B 269 TYR ASN MET ASP ARG PHE ILE ASN LYS SEQRES 1 C 269 ASN GLU GLU PHE ARG PRO GLU MET LEU GLN GLY LYS LYS SEQRES 2 C 269 VAL ILE VAL THR GLY ALA SER LYS GLY ILE GLY ARG GLU SEQRES 3 C 269 MET ALA TYR HIS LEU ALA LYS MET GLY ALA HIS VAL VAL SEQRES 4 C 269 VAL THR ALA ARG SER LYS GLU THR LEU GLN LYS VAL VAL SEQRES 5 C 269 SER HIS CYS LEU GLU LEU GLY ALA ALA SER ALA HIS TYR SEQRES 6 C 269 ILE ALA GLY THR MET GLU ASP MET THR PHE ALA GLU GLN SEQRES 7 C 269 PHE VAL ALA GLN ALA GLY LYS LEU MET GLY GLY LEU ASP SEQRES 8 C 269 MET LEU ILE LEU ASN HIS ILE THR ASN THR SER LEU ASN SEQRES 9 C 269 LEU PHE HIS ASP ASP ILE HIS HIS VAL ARG LYS SER MET SEQRES 10 C 269 GLU VAL ASN PHE LEU SER TYR VAL VAL LEU THR VAL ALA SEQRES 11 C 269 ALA LEU PRO MET LEU LYS GLN SER ASN GLY SER ILE VAL SEQRES 12 C 269 VAL VAL SER SER LEU ALA GLY LYS VAL ALA TYR PRO LEU SEQRES 13 C 269 VAL ALA ALA TYR SER ALA SER LYS PHE ALA LEU ASP GLY SEQRES 14 C 269 PHE PHE SER SER ILE ARG LYS GLU TYR SER VAL SER ARG SEQRES 15 C 269 VAL ASN VAL SER ILE THR LEU CYS VAL LEU GLY LEU ILE SEQRES 16 C 269 ASP THR GLU THR ALA MET LYS ALA VAL SER GLY ILE VAL SEQRES 17 C 269 HIS MET GLN ALA ALA PRO LYS GLU GLU CYS ALA LEU GLU SEQRES 18 C 269 ILE ILE LYS GLY GLY ALA LEU ARG GLN GLU GLU VAL TYR SEQRES 19 C 269 TYR ASP SER SER ARG TRP THR THR LEU LEU ILE ARG ASN SEQRES 20 C 269 PRO SER ARG LYS ILE LEU GLU GLU LEU TYR SER THR SER SEQRES 21 C 269 TYR ASN MET ASP ARG PHE ILE ASN LYS SEQRES 1 D 269 ASN GLU GLU PHE ARG PRO GLU MET LEU GLN GLY LYS LYS SEQRES 2 D 269 VAL ILE VAL THR GLY ALA SER LYS GLY ILE GLY ARG GLU SEQRES 3 D 269 MET ALA TYR HIS LEU ALA LYS MET GLY ALA HIS VAL VAL SEQRES 4 D 269 VAL THR ALA ARG SER LYS GLU THR LEU GLN LYS VAL VAL SEQRES 5 D 269 SER HIS CYS LEU GLU LEU GLY ALA ALA SER ALA HIS TYR SEQRES 6 D 269 ILE ALA GLY THR MET GLU ASP MET THR PHE ALA GLU GLN SEQRES 7 D 269 PHE VAL ALA GLN ALA GLY LYS LEU MET GLY GLY LEU ASP SEQRES 8 D 269 MET LEU ILE LEU ASN HIS ILE THR ASN THR SER LEU ASN SEQRES 9 D 269 LEU PHE HIS ASP ASP ILE HIS HIS VAL ARG LYS SER MET SEQRES 10 D 269 GLU VAL ASN PHE LEU SER TYR VAL VAL LEU THR VAL ALA SEQRES 11 D 269 ALA LEU PRO MET LEU LYS GLN SER ASN GLY SER ILE VAL SEQRES 12 D 269 VAL VAL SER SER LEU ALA GLY LYS VAL ALA TYR PRO LEU SEQRES 13 D 269 VAL ALA ALA TYR SER ALA SER LYS PHE ALA LEU ASP GLY SEQRES 14 D 269 PHE PHE SER SER ILE ARG LYS GLU TYR SER VAL SER ARG SEQRES 15 D 269 VAL ASN VAL SER ILE THR LEU CYS VAL LEU GLY LEU ILE SEQRES 16 D 269 ASP THR GLU THR ALA MET LYS ALA VAL SER GLY ILE VAL SEQRES 17 D 269 HIS MET GLN ALA ALA PRO LYS GLU GLU CYS ALA LEU GLU SEQRES 18 D 269 ILE ILE LYS GLY GLY ALA LEU ARG GLN GLU GLU VAL TYR SEQRES 19 D 269 TYR ASP SER SER ARG TRP THR THR LEU LEU ILE ARG ASN SEQRES 20 D 269 PRO SER ARG LYS ILE LEU GLU GLU LEU TYR SER THR SER SEQRES 21 D 269 TYR ASN MET ASP ARG PHE ILE ASN LYS HET NAP A1286 48 HET 4YQ A1287 26 HET NAP B1292 48 HET 4YQ B1293 26 HET NAP C1282 48 HET 4YQ C1283 26 HET NAP D1283 48 HET 4YQ D1284 26 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM 4YQ 4-CYCLOPROPYL-2-(2-HYDROXYETHYLOXY)-N-[(1S,3R)-5- HETNAM 2 4YQ OXIDANYL-2-ADAMANTYL]-1,3-THIAZOLE-5-CARBOXAMIDE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 5 NAP 4(C21 H28 N7 O17 P3) FORMUL 6 4YQ 4(C19 H26 N2 O4 S) FORMUL 13 HOH *605(H2 O) HELIX 1 1 ARG A 28 GLN A 33 5 6 HELIX 2 2 LYS A 44 MET A 57 1 14 HELIX 3 3 SER A 67 GLY A 82 1 16 HELIX 4 4 ASP A 95 GLY A 111 1 17 HELIX 5 5 ASP A 132 PHE A 144 1 13 HELIX 6 6 PHE A 144 ASN A 162 1 19 HELIX 7 7 SER A 170 LYS A 174 5 5 HELIX 8 8 VAL A 180 SER A 204 1 25 HELIX 9 9 THR A 220 SER A 228 1 9 HELIX 10 10 PRO A 237 LEU A 251 1 15 HELIX 11 11 SER A 261 ARG A 269 1 9 HELIX 12 12 ASN A 270 TYR A 280 1 11 HELIX 13 13 SER A 281 SER A 283 5 3 HELIX 14 14 ARG B 28 GLN B 33 5 6 HELIX 15 15 LYS B 44 MET B 57 1 14 HELIX 16 16 SER B 67 GLY B 82 1 16 HELIX 17 17 ASP B 95 GLY B 111 1 17 HELIX 18 18 ASP B 132 PHE B 144 1 13 HELIX 19 19 PHE B 144 ASN B 162 1 19 HELIX 20 20 SER B 170 LYS B 174 5 5 HELIX 21 21 VAL B 180 ARG B 205 1 26 HELIX 22 22 THR B 220 SER B 228 1 9 HELIX 23 23 PRO B 237 LEU B 251 1 15 HELIX 24 24 SER B 261 ILE B 268 1 8 HELIX 25 25 ASN B 270 THR B 282 1 13 HELIX 26 26 MET B 286 ASN B 291 1 6 HELIX 27 27 ARG C 28 GLN C 33 5 6 HELIX 28 28 LYS C 44 MET C 57 1 14 HELIX 29 29 SER C 67 GLY C 82 1 16 HELIX 30 30 ASP C 95 GLY C 111 1 17 HELIX 31 31 ASP C 132 PHE C 144 1 13 HELIX 32 32 PHE C 144 ASN C 162 1 19 HELIX 33 33 SER C 170 LYS C 174 5 5 HELIX 34 34 VAL C 180 SER C 202 1 23 HELIX 35 35 THR C 220 SER C 228 1 9 HELIX 36 36 PRO C 237 LEU C 251 1 15 HELIX 37 37 SER C 261 ILE C 268 1 8 HELIX 38 38 ASN C 270 LEU C 279 1 10 HELIX 39 39 ARG D 28 GLN D 33 5 6 HELIX 40 40 LYS D 44 MET D 57 1 14 HELIX 41 41 SER D 67 LEU D 81 1 15 HELIX 42 42 ASP D 95 GLY D 111 1 17 HELIX 43 43 ASP D 132 PHE D 144 1 13 HELIX 44 44 PHE D 144 ASN D 162 1 19 HELIX 45 45 SER D 170 LYS D 174 5 5 HELIX 46 46 VAL D 180 SER D 204 1 25 HELIX 47 47 THR D 220 SER D 228 1 9 HELIX 48 48 PRO D 237 LEU D 251 1 15 HELIX 49 49 TRP D 263 ILE D 268 1 6 HELIX 50 50 ASN D 270 LEU D 279 1 10 SHEET 1 AA 7 SER A 85 ALA A 90 0 SHEET 2 AA 7 HIS A 60 ALA A 65 1 O VAL A 61 N HIS A 87 SHEET 3 AA 7 LYS A 36 VAL A 39 1 O VAL A 37 N VAL A 62 SHEET 4 AA 7 MET A 115 LEU A 118 1 O MET A 115 N ILE A 38 SHEET 5 AA 7 SER A 164 VAL A 168 1 O SER A 164 N LEU A 116 SHEET 6 AA 7 SER A 209 LEU A 215 1 O SER A 209 N ILE A 165 SHEET 7 AA 7 GLU A 255 TYR A 258 1 O VAL A 256 N VAL A 214 SHEET 1 BA 7 SER B 85 ALA B 90 0 SHEET 2 BA 7 HIS B 60 ALA B 65 1 O VAL B 61 N HIS B 87 SHEET 3 BA 7 LYS B 36 VAL B 39 1 O VAL B 37 N VAL B 62 SHEET 4 BA 7 MET B 115 LEU B 118 1 O MET B 115 N ILE B 38 SHEET 5 BA 7 SER B 164 VAL B 168 1 O SER B 164 N LEU B 116 SHEET 6 BA 7 SER B 209 LEU B 215 1 O SER B 209 N ILE B 165 SHEET 7 BA 7 GLU B 255 TYR B 258 1 O VAL B 256 N VAL B 214 SHEET 1 CA 7 SER C 85 TYR C 88 0 SHEET 2 CA 7 HIS C 60 THR C 64 1 O VAL C 61 N HIS C 87 SHEET 3 CA 7 LYS C 36 THR C 40 1 O VAL C 37 N VAL C 62 SHEET 4 CA 7 MET C 115 LEU C 118 1 O MET C 115 N ILE C 38 SHEET 5 CA 7 SER C 164 VAL C 168 1 O SER C 164 N LEU C 116 SHEET 6 CA 7 SER C 209 LEU C 215 1 O SER C 209 N ILE C 165 SHEET 7 CA 7 GLU C 255 TYR C 258 1 O VAL C 256 N VAL C 214 SHEET 1 DA 7 SER D 85 ALA D 90 0 SHEET 2 DA 7 HIS D 60 ALA D 65 1 O VAL D 61 N HIS D 87 SHEET 3 DA 7 LYS D 36 VAL D 39 1 O VAL D 37 N VAL D 62 SHEET 4 DA 7 MET D 115 LEU D 118 1 O MET D 115 N ILE D 38 SHEET 5 DA 7 SER D 164 VAL D 168 1 O SER D 164 N LEU D 116 SHEET 6 DA 7 SER D 209 LEU D 215 1 O SER D 209 N ILE D 165 SHEET 7 DA 7 GLU D 255 TYR D 258 1 O VAL D 256 N VAL D 214 SITE 1 AC1 30 GLY A 41 SER A 43 LYS A 44 GLY A 45 SITE 2 AC1 30 ILE A 46 ALA A 65 ARG A 66 SER A 67 SITE 3 AC1 30 THR A 92 MET A 93 ASN A 119 ILE A 121 SITE 4 AC1 30 VAL A 168 SER A 169 TYR A 183 LYS A 187 SITE 5 AC1 30 LEU A 215 GLY A 216 LEU A 217 ILE A 218 SITE 6 AC1 30 THR A 220 THR A 222 ALA A 223 4YQ A1287 SITE 7 AC1 30 HOH A2015 HOH A2016 HOH A2018 HOH A2044 SITE 8 AC1 30 HOH A2096 HOH A2188 SITE 1 AC2 34 GLY B 41 ALA B 42 SER B 43 LYS B 44 SITE 2 AC2 34 GLY B 45 ILE B 46 ALA B 65 ARG B 66 SITE 3 AC2 34 SER B 67 THR B 92 MET B 93 ASN B 119 SITE 4 AC2 34 ILE B 121 VAL B 168 SER B 169 SER B 170 SITE 5 AC2 34 TYR B 183 LYS B 187 LEU B 215 GLY B 216 SITE 6 AC2 34 LEU B 217 ILE B 218 THR B 220 THR B 222 SITE 7 AC2 34 ALA B 223 4YQ B1293 HOH B2008 HOH B2009 SITE 8 AC2 34 HOH B2012 HOH B2032 HOH B2132 HOH B2164 SITE 9 AC2 34 HOH B2165 HOH B2166 SITE 1 AC3 35 GLY C 41 ALA C 42 SER C 43 LYS C 44 SITE 2 AC3 35 GLY C 45 ILE C 46 ALA C 65 ARG C 66 SITE 3 AC3 35 SER C 67 THR C 92 MET C 93 ASN C 119 SITE 4 AC3 35 ILE C 121 VAL C 168 SER C 169 SER C 170 SITE 5 AC3 35 TYR C 183 LYS C 187 LEU C 215 GLY C 216 SITE 6 AC3 35 LEU C 217 ILE C 218 THR C 220 THR C 222 SITE 7 AC3 35 ALA C 223 4YQ C1283 HOH C2010 HOH C2011 SITE 8 AC3 35 HOH C2012 HOH C2013 HOH C2014 HOH C2025 SITE 9 AC3 35 HOH C2061 HOH C2151 HOH C2152 SITE 1 AC4 29 GLY D 41 ALA D 42 SER D 43 LYS D 44 SITE 2 AC4 29 GLY D 45 ILE D 46 ALA D 65 ARG D 66 SITE 3 AC4 29 SER D 67 THR D 92 MET D 93 ASN D 119 SITE 4 AC4 29 ILE D 121 VAL D 168 SER D 169 SER D 170 SITE 5 AC4 29 TYR D 183 LYS D 187 LEU D 215 GLY D 216 SITE 6 AC4 29 LEU D 217 ILE D 218 THR D 220 THR D 222 SITE 7 AC4 29 ALA D 223 4YQ D1284 HOH D2007 HOH D2025 SITE 8 AC4 29 HOH D2074 SITE 1 AC5 13 SER A 170 TYR A 177 TYR A 183 LEU A 215 SITE 2 AC5 13 GLY A 216 LEU A 217 MET A 233 ASP A 259 SITE 3 AC5 13 NAP A1286 HOH A2097 HOH A2160 TYR B 280 SITE 4 AC5 13 TYR B 284 SITE 1 AC6 17 TYR A 280 TYR A 284 THR B 124 SER B 170 SITE 2 AC6 17 LEU B 171 TYR B 177 TYR B 183 LEU B 215 SITE 3 AC6 17 GLY B 216 LEU B 217 THR B 222 ALA B 226 SITE 4 AC6 17 MET B 233 ASP B 259 NAP B1292 HOH B2081 SITE 5 AC6 17 HOH B2164 SITE 1 AC7 16 THR C 124 LEU C 126 SER C 170 TYR C 177 SITE 2 AC7 16 TYR C 183 LEU C 215 GLY C 216 LEU C 217 SITE 3 AC7 16 THR C 222 ALA C 226 MET C 233 ASP C 259 SITE 4 AC7 16 NAP C1282 HOH C2063 HOH C2151 TYR D 280 SITE 1 AC8 10 LEU D 126 SER D 170 TYR D 177 TYR D 183 SITE 2 AC8 10 LEU D 215 LEU D 217 ALA D 226 ASP D 259 SITE 3 AC8 10 NAP D1283 HOH D2042 CRYST1 95.686 98.435 99.112 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010451 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010159 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010090 0.00000